Press release
Real World Evidence: Market Landscape and Competitive Insights, 2018-2030
Roots Analysis has announced the addition of “Real World Evidence: Market Landscape and Competitive Insights, 2018-2030” report to its list of offerings.Prabhjot Kaur, the principal analyst, stated, “Currently, close to 200 industry players are actively involved in providing real world data / analytics / services to the pharmaceutical and life sciences industries. Of these, more than 120 players leverage clinical data (derived from medical and patient care records) and patient experience data for generating actionable insights. It is worth highlighting that, in the past few years, more than 1,000 clinical studies have been initiated by stakeholders in real world setting to assess the impact of pharmacologic / non-pharmacologic treatment on patients and healthcare systems The growing importance of real world evidence in healthcare decision-making is also evident from the number of tweets (~4,400) posted on the social media platform, Twitter, in recent years.”
The report presents opinions on several key aspects of the market. Among other elements, it includes:
• An overview of the current status of the market with respect to the companies providing real world evidence related solutions. It features information on their year of establishment, geographical location, size of the company, type of offering (real world data, analytics, and services), real world data sources (medical claims, clinical trials, clinical setting, pharmacy, patient-powered and others), and intended application areas (early stage research, clinical development, regulatory submission / reimbursement / market access, and post-approval studies).
• A detailed publication analysis of close to 500 articles that have been published since 2016, highlighting the key focus areas of ongoing real world evidence-based research activity in the pharmaceutical and life sciences industries. Industry stakeholders that have made significant contributions to the intellectual capital in this domain include (in decreasing order of number of publications) Merck, IQVIA, GlaxoSmithKline, Eli Lilly, Novartis, PPD (Evidera), Janssen Pharmaceutica, AstraZeneca, Amgen, and Pfizer.
• A comprehensive analysis of more than 1,000 completed, ongoing and planned studies conducted in the real world setting. Based on the number of trials, North America (~460 trials) has emerged as a major research / innovation hub in this domain. It is also worth highlighting that a relatively larger proportion of the trials evaluated patients suffering from oncological disorders, cardiovascular disorders, neurological and psychiatric disorders.
• An analysis depicting the prevalent and emerging trends related to this domain as represented on the social media platform, Twitter. In addition to providing information on yearly trends related to the volume of tweets since 2013, the analysis highlights the most frequently talked about real world data sources, applications, therapeutic areas, active players, and influential authors.
• An in-depth analysis of close to 75 global events (summits / forums / conferences / annual meetings) that were organized for stakeholders in this domain (since 2017), highlighting the evolution of discussion topics related to real world evidence. The analysis also provides details on event type, regional distribution, emerging agendas, popular organizers, active industry and non-industry players, and a schematic mapping of upcoming planned events.
• A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall real world evidence market.
• A comparative analysis of the needs of different stakeholders (manufacturers, regulators, payers, providers and patients) involved in this domain.
• A list of recent cases where real world evidence was leveraged by pharmaceutical / medical device companies, highlighting the ways in which the companies have utilized such information to support regulatory decisions, advance disease understanding, and develop outcome-based reimbursement model.
• An elaborate discussion on data governance and the existing regulatory framework related to real world evidence across various geographies, namely North America (the US and Canada), Europe (the UK, Germany, France, Spain and Italy), and Asia-Pacific (Australia, China and Japan).
• An insightful opportunity analysis, estimating the existing market size and potential growth opportunities across different applications (early stage research, clinical development, regulatory approval, pricing / reimbursement, and post-approval studies) of real world evidence. It is important to mention that North America and Europe presently dominate the market and are expected to retain the leading position over the next decade. This is followed by Asia-Pacific and the rest of the world, which currently captures around 10% of the overall market share.
The report features inputs from a number of eminent industry stakeholders. Kaur remarked, “Most of the experts we spoke to concur on the opinion that real world evidence has the potential to be utilized effectively across all stages of product development and commercialization. Experts also claim that the use of real world evidence can potentially reduce drug approval timelines by about five years, and the required investment in R&D by 50-60%.” The report features detailed transcripts of interviews held with the following individuals:
• Jane Reed (Head of Life Science Strategy, Linguamatics)
• Jonathan Moshinsky (Head of Market Strategy, uMotif)
• Mark Cziraky (Vice President of Research, HealthCore)
• Anonymous (Vice President, Big Pharmaceutical Company)
The report covers detailed assessment of real world evidence related solutions of several companies, including (illustrative list, no selection criteria):
• Aetion
• Clinakos
• Clinigen
• Flatiron Health
• HealthCore
• IBM Watson Health
• ICON
• Ignite Data
• Ingress
• IQVIA
• Linguamatics
• MaxisIT
• PARAXEL
• PatientsLikeMe
• pH Associates
• RealHealthData
• Saama Technologies
• SAS Institute
• SHYFT Analytics
• uMotif
• Vector Oncology
• Wipro
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you'd like us to help you with your growing business needs, get in touch at info@rootsanalysis.com
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/real-world-evidence-market-landscape-and-competitive-insights-2018-2030-/228.html
or email sales@rootsanalysis.com
Contact:
Gaurav Chaudhary
+1-604-595-4954
gaurav.chaudhary@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Real World Evidence: Market Landscape and Competitive Insights, 2018-2030 here
News-ID: 1379667 • Views: …
More Releases from Roots Analysis

Proteomics Market CAGR To Be 7.9% % by 2035, Due To The Growing Adoption of Prot …
According to our latest market report "Proteomics Market" by Type of Offering, Type of Instrument / Technology, Type of Reagent, Type of Proteomics Service, Application Area, End-users, Type of Operation and Geography: Industry Trends and Global Forecasts, Till 2035", the global protein expression market, valued at USD 2.7 billion in 2024, is estimated to reach USD 3.0 billion in 2025 and USD 6.3 billion by 2035, representing a CAGR of…

Industrial Robotics Market to Reach USD 39.03 Billion by 2035, Driven by Rising …
09-04-2025 | Robotics & Automation
Press release from: Roots Analysis
According to Roots Analysis' latest industry report titled "Industrial Robotics Market: Industry Trends and Global Forecasts, till 2035", the global industrial robotics market is projected to grow from USD 17.64 billion in 2024 to USD 18.80 billion in 2025, reaching USD 39.03 billion by 2035 at a CAGR of 7.5% during the forecast period.
To request a quote for this report, visit:
https://www.rootsanalysis.com/industrial-robotics-market/request-quote
Market Overview
Industrial…

Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | R …
According to our latest market report "Targeted Drug Delivery Device Market" by Type of Device, Target Organ, Type of Therapy Delivered, Route of Administration, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the targeted drug delivery device market size is projected to reach USD 2,153 million by 2035 from USD 427 million in 2026, growing at a CAGR of 19.7% in the forecast period, till…

The Conjugation and Labeling Services Market is projected to grow at a CAGR of 1 …
The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market/request-quote.html
Roots Analysis is pleased to announce the publication of its recent study, titled, "Conjugation and Labeling Services Market, 2023-2035"
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies.…
More Releases for Health
Health Coach Market Positioned for Accelerated Growth with Iora Health, Virta He …
Global health coach market is estimated to be valued at USD 18.83 Bn in 2025 and is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.
Latest Report on the Health Coach Market 2025-2032, focuses on a comprehensive analysis of the current and future prospects of the Health Coach Market industry. An in-depth analysis of historical trends, future trends,…
Digital Therapeutics Market Research 2025 Leading Key Players - Proteus Digital …
An exclusive Digital Therapeutics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Digital Therapeutics Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report…
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification.
This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market,…
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C.
Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and…
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025
This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis.
Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and…
Digital Therapeutics Market Global Outlook to 2025 - Proteus Digital Health, Wel …
“Digital Therapeutics Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc.
The market of digital therapeutics market is anticipated to grow with a significant rate in the coming years, owing…